{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:51:21Z","timestamp":1789696281843,"version":"4.0.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.jaad.2007.01.016","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T17:21:25Z","timestamp":1173374485000},"page":"335.e1-335.e29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Treatment of acute Old World cutaneous leishmaniasis: A systematic review of the randomized controlled trials"],"prefix":"10.1016","volume":"57","author":[{"given":"Alireza","family":"Khatami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Firooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzam","family":"Gorouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Dowlati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.01.016_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.jaad.2007.01.016_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0738-081X(96)00058-2","article-title":"Cutaneous leishmaniasis: clinical aspect","volume":"14","author":"Dowlati","year":"1996","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0738-081X(96)00047-8","article-title":"Treatment of cutaneous leishmaniasis (Old World)","volume":"14","author":"Dowlati","year":"1996","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2230.2006.02182.x","article-title":"Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial","volume":"31","author":"Asilian","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4269\/ajtmh.1995.52.166","article-title":"A randomized, double-blind, clinical trial of topical clotrimazole versus miconazole for treatment of cutaneous leishmaniasis in the eastern province of Saudi Arabia","volume":"52","author":"Larbi","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2007.01.016_bib6","first-page":"73","article-title":"Intralesional injection of 2% zinc sulfate solution in the treatment of acute Old World cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial","volume":"4","author":"Firooz","year":"2005","journal-title":"J Drug Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1365-4362.1999.00727.x","article-title":"A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran","volume":"38","author":"Zerehsaz","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib8","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.01.016_bib9","series-title":"Evidence-based dermatology","first-page":"44","article-title":"The hierarchy of evidence","author":"Bigby","year":"2003"},{"key":"10.1016\/j.jaad.2007.01.016_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jaad.2007.01.016_bib11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.jaad.2007.01.016_bib12","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/00034983.1997.11813217","article-title":"Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration","volume":"91","author":"Alkhawajah","year":"1997","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.jaad.2007.01.016_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-4362.1999.00769.x","article-title":"Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis","volume":"38","author":"Mujtaba","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/136485905X16372","article-title":"Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran","volume":"99","author":"Iraji","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.jaad.2007.01.016_bib15","first-page":"85","article-title":"Comparison of topical paromomycin sulfate (twice\/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major","volume":"15","author":"Shazad","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib16","first-page":"353","article-title":"Treatment of cutaneous leishmaniasis with a four-week regimen of aminosidine ointment (Paromomycin) in Iran","volume":"81","author":"Asilian","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaad.2007.01.016_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2230.2003.01169.x","article-title":"Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate","volume":"28","author":"Faghihi","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-4362.1997.00022.x","article-title":"A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey","volume":"36","author":"Ozgostasi","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4269\/ajtmh.1995.53.648","article-title":"A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran","volume":"53","author":"Asilian","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2007.01.016_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.1995.53.162","article-title":"A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment","volume":"53","author":"Ben Salah","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2007.01.016_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(92)70175-F","article-title":"Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study","volume":"27","author":"el-On","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0035-9203(90)90146-6","article-title":"A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment","volume":"84","author":"el-Safi","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2007.01.016_bib23","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bmj.291.6497.704","article-title":"Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride","volume":"291","author":"el-On","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jaad.2007.01.016_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1468-3083.2004.01133.x","article-title":"A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis","volume":"19","author":"Nassiri-Kashani","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2007.01.016_bib25","first-page":"97","article-title":"[Comparison of efficacy of oral fluconazole with intramuscular Glucantime in patients with acute cutaneous leishmaniasis]","volume":"8","author":"Family","year":"2005","journal-title":"Iran J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/09546630305552","article-title":"Treatment of cutaneous leishmaniasis with ketoconazole cream","volume":"14","author":"Momeni","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2007.01.016_bib27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.01.016_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09546630152607899","article-title":"Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis","volume":"12","author":"Salmanpour","year":"2001","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2007.01.016_bib29","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archderm.1996.03890310070009","article-title":"Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study","volume":"132","author":"Momeni","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib30","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0020-7519(96)00128-2","article-title":"Itraconazole and leishmaniasis: a randomized double-blind trial in cutaneous disease","volume":"26","author":"Dogra","year":"1996","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.jaad.2007.01.016_bib31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-4362.1995.tb00622.x","article-title":"Ketoconazole in the treatment of cutaneous leishmaniasis in Kuwait","volume":"34","author":"Alsaleh","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-4362.1991.tb04878.x","article-title":"Cutaneous leishmaniasis in Kuwait. Clinical experience with itraconazole","volume":"30","author":"al-Fouzan","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-4362.1990.tb02593.x","article-title":"Cutaneous leishmaniasis in India. Clinical experience with itraconazole (R51 211 Janssen)","volume":"29","author":"Dogra","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000078586","article-title":"Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis","volume":"209","author":"Iraji","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.01.016_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2230.2001.00752.x","article-title":"Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis","volume":"26","author":"Sharquie","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2230.1997.tb01054.x","article-title":"A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis","volume":"22","author":"Sharquie","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib38","first-page":"136","article-title":"[Efficacy of combined triple therapy (paramomycin ointment, cryotherapy and intralesional Glucantime) in comparison with intralesional Glucantime for the treatment of acute cutaneous leishmaniasis]","volume":"7","author":"Nilforooshzadeh","year":"2004","journal-title":"Iran J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1179\/000349803225001373","article-title":"The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis","volume":"97","author":"Asilian","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.jaad.2007.01.016_bib40","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archderm.142.12.1575","article-title":"Imiquimod in combination with meglumine antimoniate for acute cutaneous leishmaniasis: a randomized assessor-blind controlled trial","volume":"142","author":"Firooz","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-4632.2006.02867.x","article-title":"Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis","volume":"45","author":"Sadeghian","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib42","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/428736","article-title":"Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomised, controlled trial","volume":"40","author":"Reithinger","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2007.01.016_bib43","first-page":"340","article-title":"A comparative study on the efficacy of combination therapy with omeprazole and low dose systemic meglumine antimoniate (Glucantime) and the full dose systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis","volume":"8","author":"Nilforoushzadeh","year":"2005","journal-title":"Iran J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib44","first-page":"251","article-title":"A comparison between intralesional hypertonic sodium chloride solution and meglumine antimoniate (Glucantime) injections in the treatment of cutaneous leishmaniasis","volume":"8","author":"Sadeghian","year":"2005","journal-title":"Iran J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2007.01.016_bib45","first-page":"S118","article-title":"Comparative study of the efficacy of combined imiquimod 5% cream and intralesional meglumine antimoniate versus imiquimod 5% cream and intralesional meglumine antimoniate alone for the treatment of cutaneous leishmaniasis","volume":"52","author":"Crawford","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-4632.2004.02349.x","article-title":"Evaluation of CO2 laser efficacy in the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib47","first-page":"34","article-title":"[Topical trichloroacetic acid compared with intralesional Glucantime injection in the treatment of acute wet cutaneous leishmaniasis: an open clinical trial]","volume":"6","author":"Nilforoushzadeh","year":"2003","journal-title":"Iran J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-4362.2002.01526.x","article-title":"Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis","volume":"41","author":"Esfandiarpour","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib49","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-4362.2002.01527.x","article-title":"Treatment of cutaneous leishmaniasis with a combination of allopurinol and\u00a0low-dose meglumine antimoniate","volume":"41","author":"Momeni","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0035-9203(01)90158-0","article-title":"Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B","volume":"95","author":"Vardy","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2007.01.016_bib51","first-page":"23","article-title":"[Assessment of the effect of topical opium in treatment of cutaneous leishmaniasis]","volume":"4","author":"Mapar","year":"2001","journal-title":"Iran J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib52","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/qjmed\/93.11.733","article-title":"The role of rifampicin in the management of cutaneous leishmaniasis","volume":"93","author":"Kochar","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.jaad.2007.01.016_bib53","first-page":"2","article-title":"[Treatment of cutaneous leishmaniasis with 5% garlic cream: a randomized double blind study]","volume":"3","author":"Gholami","year":"2000","journal-title":"Iran J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib54","first-page":"13","article-title":"Local application of diminazene aceturate: an effective treatment for cutaneous leishmaniasis?","volume":"72","author":"Lynen","year":"1992","journal-title":"Ann Soc Belg Med Trop"},{"key":"10.1016\/j.jaad.2007.01.016_bib55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0035-9203(91)90025-T","article-title":"A double-blind study on the efficacy of oral dapsone in cutaneous leishmaniasis","volume":"85","author":"Dogra","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2007.01.016_bib56","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0035-9203(91)90026-U","article-title":"A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in\u00a0the local treatment of cutaneous leishmaniasis","volume":"85","author":"Harms","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2007.01.016_bib57","first-page":"1125","article-title":"Topical application of human fibroblast interferon (IFN) in cutaneous leishmaniasis","volume":"23","author":"Trau","year":"1987","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.jaad.2007.01.016_bib58","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-4362.1986.tb03435.x","article-title":"Dapsone in the treatment of cutaneous leishmaniasis","volume":"25","author":"Dogra","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/341406","article-title":"A\u00a0randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel","volume":"35","author":"Wortmann","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2007.01.016_bib60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2133.1988.tb07100.x","article-title":"Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony","volume":"119","author":"Sharquie","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib61","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-4362.1996.tb03669.x","article-title":"Cutaneous leishmaniasis: Schedules for intralesional treatment with sodium stibogluconate","volume":"35","author":"Tallab","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib62","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-4632.2006.02822.x","article-title":"Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis","volume":"45","author":"Salmanpour","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib63","first-page":"1512","article-title":"Treatment of cutaneous leishmaniasis by intralesional metronidazole","volume":"25","author":"Al-Waiz","year":"2004","journal-title":"Saudi Med J"},{"key":"10.1016\/j.jaad.2007.01.016_bib64","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1365-4362.2003.01955.x","article-title":"Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod","volume":"42","author":"Seeberger","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib65","first-page":"20","article-title":"[Oral zinc sulfate in the treatment of acute cutaneous leishmaniasis]","volume":"2","author":"Yazdan Panah","year":"2003","journal-title":"Iran J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib66","first-page":"30","article-title":"[Comparison of efficacy of cryotherapy and intralesional Glucantime injection with cryotherapy alone in treating papulonodular cutaneous leishmaniasis]","volume":"2","author":"Asilian","year":"2003","journal-title":"Iran J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2007.01.016_bib67","first-page":"24","article-title":"[Treatment of\u00a0cutaneous leishmaniasis with ketoconazole ointment: a randomized double blind study]","volume":"1","author":"Momeni","year":"2001","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.jaad.2007.01.016_bib68","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1468-3083.1999.tb00886.x","article-title":"Treatment of cutaneous leishmaniasis with 20% paromomycin ointment","volume":"13","author":"Stanimirovic","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2007.01.016_bib69","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archderm.135.7.856","article-title":"Topical amphotericin B for cutaneous leishmaniasis","volume":"135","author":"Vardy","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib70","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09546639809160701","article-title":"Treatment of cutaneous leishmaniasis with itraconazole","volume":"9","author":"Siddighi","year":"1998","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2007.01.016_bib71","first-page":"100","article-title":"[Efficacy of CO2 laser in the treatment of cutaneous leishmaniasis in Isfahan region]","volume":"2","author":"Asilian","year":"1998","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.jaad.2007.01.016_bib72","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1365-2133.1998.02105.x","article-title":"Intralesional treatment of\u00a0cutaneous leishmaniasis with meglumine antimoniate","volume":"138","author":"Aste","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib73","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-4362.1995.tb03595.x","article-title":"Failure of ketoconazole treatment in cutaneous leishmaniasis","volume":"34","author":"Singh","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib74","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-4362.1995.tb03598.x","article-title":"Treatment of recurrent cutaneous Leishmaniasis","volume":"34","author":"Momeni","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib75","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-4362.1994.tb01049.x","article-title":"Treatment of cutaneous leishmaniasis with oral itraconazole","volume":"33","author":"Van den Enden","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib76","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-4362.1993.tb05044.x","article-title":"Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony","volume":"32","author":"Faris","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib77","first-page":"14","article-title":"Evaluation of topical ketoconazole in cutaneous leishmaniasis","volume":"69","author":"Abahusein","year":"1992","journal-title":"East Afr Med J"},{"key":"10.1016\/j.jaad.2007.01.016_bib78","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-4362.1989.tb02541.x","article-title":"Dermal leishmaniasis and rifampicin","volume":"28","author":"Joshi","year":"1989","journal-title":"Int\u00a0J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-4362.1987.tb04578.x","article-title":"Efficacy of rifampicin and isoniazid in cutaneous leishmaniasis","volume":"26","author":"Livshin","year":"1987","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib80","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-4362.1986.tb03461.x","article-title":"Cryotherapy in acute cutaneous leishmaniasis","volume":"25","author":"Leibovici","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib81","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-4362.1986.tb03460.x","article-title":"Treatment of cutaneous leishmaniasis with infrared heat","volume":"25","author":"Junaid","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-4362.1984.tb05669.x","article-title":"Combination therapy of sodium stibogluconate and rifampin in cutaneous leishmaniasis","volume":"23","author":"Pareek","year":"1984","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib83","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2007.01.016_bib84","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","article-title":"Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004","volume":"5","author":"Olliaro","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaad.2007.01.016_bib85","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jaad.2005.07.026","article-title":"Leishmania tropica in northern Israel: a clinical overview of an emerging focus","volume":"53","author":"Shani-Adir","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib86","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1371\/journal.pmed.0030162","article-title":"Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites","volume":"3","author":"Hadighi","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaad.2007.01.016_bib87","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwalt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.01.016_bib88","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaad.2007.01.016_bib89","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2007.01.016_bib90","series-title":"Textbook of clinical trials","first-page":"11","article-title":"General issues","author":"Machin","year":"2004"},{"key":"10.1016\/j.jaad.2007.01.016_bib91","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-4362.1997.00149.x","article-title":"Old World cutaneous leishmaniasis","volume":"36","author":"Samady","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib92","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-4362.1994.tb01039.x","article-title":"Clinical picture of cutaneous leishmaniasis in Isfahan, Iran","volume":"33","author":"Momeni","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.01.016_bib93","first-page":"399","article-title":"Current scenario of drug development for leishmaniasis","volume":"123","author":"Croft","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jaad.2007.01.016_bib94","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","article-title":"Treatment of\u00a0cutaneous leishmaniasis among travellers","volume":"53","author":"Blum","year":"2004","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207002010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207002010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:07:09Z","timestamp":1759270029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207002010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0190962207002010"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.01.016","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of acute Old World cutaneous leishmaniasis: A systematic review of the randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}